If you visit our website, you know that the use of marijuana in women of reproductive age is on the rise and that we are concerned about it. The FDA has put out a [...]
In the United States, about one out of every 160 pregnancies ends in stillbirth, defined as a pregnancy loss occurring after 20 weeks’ gestation. Perinatal loss is a traumatic event for women and their [...]
Previous studies have demonstrated that children born to mothers who smoke during pregnancy are at increased risk for attention-deficit/hyperactivity disorder (ADHD). In a recent review, Huang and colleagues looked at data from 15 cohort [...]
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on diagnosing and treating postpartum psychosis with Ob.Gyn News on January 30th, 2020 Although [...]
Several articles from the Journal of Clinical Psychiatry report on suicidal and self-harm ideation in pregnant and postpartum women. Not surprisingly, a history of psychiatric illness increases risk; however, other factors play an important [...]
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, [...]
While we have considerable data regarding the reproductive safety of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs), most studies have focused on the prevalence of major malformations in children with prenatal exposure to [...]
After accidental deaths, suicide is the second leading cause of death in those between the ages of 10 and 19 years. Â Historically, suicide rates have been higher for male than for female youth; [...]
We are excited to offer the next round of the MGH Women’s Mental Health online CME program. Thank you for those who participated in the fall. The next course starts February 10, and we [...]
We hope everybody is settling into the New Year. Here's a look back at what happened in 2019. Brexanolone takes the lead as our top story for 2019.  Brexanolone (introduced as SAGE-547 by SAGE Therapeutics) [...]
